Prospective Multidisciplinary Post-COVID-19 Registry Tyrol
PRECISE
1 other identifier
observational
600
1 country
1
Brief Summary
Longitudinal, prospective observational cohort study enrolling patients with persisting symptoms (\> 12 weeks) after COVID-19 in a multidisciplinary care model.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 3, 2022
CompletedFirst Submitted
Initial submission to the registry
August 19, 2022
CompletedFirst Posted
Study publicly available on registry
September 19, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedSeptember 19, 2022
August 1, 2022
1.8 years
August 19, 2022
September 16, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Prevalence rates of post-COVID patients requiring multidisciplinary care.
To quantify disease burden by prevalence rates of post-COVID patients requiring multidisciplinary care.
2 years
Characterisation of symptom patterns associated with impaired functional status.
Characterisation of symptom patterns associated with impaired post covid-19 functional status scale ≥ 2.
up to 24 months
Eligibility Criteria
Eligible patients will be screened by primary physicians in Tyrol (Wester Austria) using the post-COVID-19 functional status (PCFS) scale to assess the functional status, and a symptom checklist for the presence and severity of the 10 most common symptoms.
You may qualify if:
- Individuals with persistent post COVID symptoms ≥ 12 weeks
- post COVID functional status scale (PCFS) ≥ 2
You may not qualify if:
- observation time after infection \< 12 weeks
- PCFS \< 2
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University of Innsbruck
Innsbruck, 6020, Austria
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 19, 2022
First Posted
September 19, 2022
Study Start
March 3, 2022
Primary Completion
December 31, 2023
Study Completion
December 31, 2025
Last Updated
September 19, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- Beginning three months after publication and ending five years following article publication.
- Access Criteria
- Access to researchers who provide a methodologically sound proposal.
We provide all of the individual participant data collected during the trial after deidentification and to researchers who provide a methodologically sound proposal.